We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO icon
Marathon Oil Corporation
MRO
+$123M
5
CHX icon
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS icon
Discover Financial Services
DFS
+$45.1M
4
SCRM icon
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
KALA icon
276
KALA BIO
KALA
$5.68M
$1.05M 0.03%
2,951
+1,500
+103% +$496K
2024 Q1
1 quarter
MFA icon
277
MFA Financial
MFA
$695M
$1.04M 0.03%
97,421
-12,379
-11% -$133K
2024 Q1
1 quarter
ON icon
278
ON Semiconductor
ON
$30.2B
$1.03M 0.03%
15,000
-12,500
-45% -$877K
2023 Q1
5 quarters
KROS icon
279
Keros Therapeutics
KROS
$237M
$1.03M 0.03%
22,453
+5,400
+32% +$290K
2022 Q1
9 quarters
ATXS icon
280
DELISTED
Astria Therapeutics
ATXS
$1.03M 0.03%
112,665
+4,545
+4% +$44.4K
2023 Q2
4 quarters
OFIX icon
281
Orthofix Medical
OFIX
$374M
$1.02M 0.03%
76,998
-7,251
-9% -$99.4K
2023 Q1
5 quarters
PTCT icon
282
PTC Therapeutics
PTCT
$5.4B
$1.01M 0.03%
33,000
+18,000
+120% +$583K
2022 Q4
6 quarters
XRX icon
283
PUT
Xerox
XRX
$361M
$998K 0.03%
278,300
-16,500
-6% -$240K
2021 Q2
12 quarters
AXGN icon
284
Axogen
AXGN
$2.12B
$996K 0.03%
137,575
– –
2022 Q1
9 quarters
RCUS icon
285
Arcus Biosciences
RCUS
$3.11B
$993K 0.03%
65,187
+1,065
+2% +$17.2K
2022 Q2
8 quarters
PEN icon
286
Penumbra
PEN
$12.6B
$989K 0.03%
5,498
-300
-5% -$59.9K
2022 Q1
9 quarters
SMAR icon
287
DELISTED
Smartsheet Inc.
SMAR
$988K 0.03%
+22,416
New +$894K
2024 Q2
0 quarters
PTON icon
288
PUT
Peloton Interactive
PTON
$2.25B
$978K 0.03%
500,000
-225,000
-31% -$806K
2023 Q1
5 quarters
DECK icon
289
Deckers Outdoor
DECK
$11.3B
$968K 0.03%
+6,000
New +$923K
2024 Q2
0 quarters
ARCO icon
290
Arcos Dorados Holdings
ARCO
$1.64B
$963K 0.03%
+107,023
New +$1.1M
2024 Q2
0 quarters
KPTI icon
291
Karyopharm Therapeutics
KPTI
$13.7M
$957K 0.03%
73,493
+25,338
+53% +$420K
2022 Q1
9 quarters
VRT icon
292
Vertiv
VRT
$93.5B
$952K 0.03%
11,000
-54,300
-83% -$4.94M
2023 Q4
2 quarters
INSM icon
293
Insmed
INSM
$22B
$949K 0.03%
14,169
-39,338
-74% -$1.53M
2022 Q1
9 quarters
ABT icon
294
Abbott
ABT
$172B
$935K 0.03%
+9,000
New +$954K
2024 Q2
0 quarters
BBIO icon
295
BridgeBio Pharma
BBIO
$12.8B
$925K 0.03%
+36,500
New +$998K
2024 Q2
0 quarters
INZY icon
296
DELISTED
Inozyme Pharma
INZY
$915K 0.03%
205,218
+22,000
+12% +$107K
2022 Q2
8 quarters
BTG icon
297
B2Gold
BTG
$6.94B
$904K 0.03%
+334,874
New +$904K
2024 Q2
0 quarters
TRIS icon
298
DELISTED
Tristar Acquisition I Corp.
TRIS
$899K 0.03%
80,656
– –
2021 Q4
10 quarters
CPT icon
299
Camden Property Trust
CPT
$11.3B
$898K 0.03%
8,227
+3,852
+88% +$398K
2022 Q2
8 quarters
PTON icon
300
Peloton Interactive
PTON
$2.25B
$879K 0.02%
+260,000
New +$931K
2024 Q2
0 quarters
10 11
12
13 14

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.